Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05878184 |
Title | Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Sana Biotechnology |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | Duarte | California | 91010 | United States | Details | |
Stanford Cancer Institute | Palo Alto | California | 94304 | United States | Details | |
Northside Hospital | Atlanta | Georgia | 30342 | United States | Details | |
University of Kansas Medical Center | Fairway | Kansas | 66205 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Royal Adelaide Hospital | Adelaide | South Australia | 5000 | Australia | Details | |
Peter MacCallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
Linear Clinical Research Ltd | Nedlands | Western Australia | 6009 | Australia | Details |